EFFECT OF INOCULATING THE FEMALE LINE OF BROILER CHICKENS WITH DIFFERENT LEVELS OF ANASTROZOLE ON SERUM PHYSIOLOGICAL PREFORMANCE

The research took place between September 28 and November 15 at Al-Qasim Green University's chicken farm, Department of Animal Production, College of Agriculture. The purpose of this research is to determine how various doses of anastrozole affect physiological features in a female-line of broiler chickens. Twenty-four Lohmann Brown roosters were utilized in this experiment, split evenly among four different treatments. Each treatment had six duplicates, with one rooster serving as a replicate for all four treatments. As for the experimental therapies, they were as follows: First (T1) was a placebo group where the aromatase inhibitor (anastrozole) was not administered. Anastrozole capsules were dosed at 0.2 mg, 0.4 mg, and 0.6 mg in the second, third, and fourth treatments (T2, T3, and T4), one capsule per day, and the total protein and globulin concentrations were found to be significantly higher (P≤0.05) for the fourth treatment compared to the control treatment. while the results indicated a significant decrease (P≤0.05) for both cholestatic liver disease and hepatic lipid This study concludes that a 0.6 mg dosage of anastrozole has a significant impact in enhancing some physiological features of blood serum.